Neurocrine Biosciences
NBIX
#1505
Rank
C$16.50 B
Marketcap
$165.53
Share price
0.50%
Change (1 day)
-13.12%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): C$0.70 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are C$2.35 Billion. , an increase over its 2023 earnings that were of C$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 C$0.73 B64.57%
2023 C$0.44 B41.13%
2022 C$0.31 B73.74%
2021 C$0.18 B-8.82%
2020 C$0.19 B77.78%
2019 C$0.11 B49.83%
2018 C$74.61 M-142.57%
2017 -C$0.18 Billion-14.73%
2016 -C$0.21 Billion53.15%
2015 -C$0.14 Billion46.25%
2014 -C$91.78 Million29.66%
2013 -C$70.78 Million-3530.8%
2012 C$2.06 M-95.73%
2011 C$48.33 M
2009 -C$67.95 Million-45.38%
2008 -C$0.13 Billion-58.87%
2007 -C$0.31 Billion87.3%
2006 -C$0.17 Billion351.97%
2005 -C$35.73 Million-52.09%
2004 -C$74.57 Million-10.98%
2003 -C$83.76 Million
2001 -C$62.53 Million
1999 -C$28.2 Million108.32%
1998 -C$13.54 Million
1996 C$4.13 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$27.38 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.21 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-C$38.38 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.06 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.29 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.83 B 2,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$31.65 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$59.51 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA